A New Treatment for Portal Hypertension?

[1]  J. Bosch,et al.  Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. , 2016, Gastroenterology.

[2]  G. Garcia‐Tsao,et al.  Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. , 2016, Gastroenterology.

[3]  D. Rockey,et al.  Integrin‐linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[4]  G. Garcı́a-Cardeña,et al.  KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins , 2014, Gut.

[5]  D. Rockey,et al.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. , 2014, Journal of hepatology.

[6]  D. Rockey,et al.  A Risk Scoring System to Predict In-hospital Mortality in Patients With Cirrhosis Presenting With Upper Gastrointestinal Bleeding , 2014, Journal of clinical gastroenterology.

[7]  Jiezhun Gu,et al.  Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network , 2014, Hepatology.

[8]  S. Olafsson,et al.  Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.

[9]  J. Bae,et al.  Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepat , 2012, Journal of clinical lipidology.

[10]  J. García‐Pagán,et al.  Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial , 2009, Gut.

[11]  F. Nevens,et al.  Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho‐kinase and activation of endothelial nitric oxide synthase , 2007, Hepatology.

[12]  J. Bosch,et al.  Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. , 2007, Journal of hepatology.

[13]  Don C Rockey,et al.  A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension , 2005, Nature Medicine.

[14]  Charles J. Kahi,et al.  Improved Patient Survival After Acute Variceal Bleeding: A Multicenter, Cohort Study , 2003, American Journal of Gastroenterology.

[15]  D. Rockey,et al.  Gastroesophageal variceal hemorrhage. , 2001, The New England journal of medicine.

[16]  J. García‐Pagán,et al.  Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis☆☆☆ , 2001 .

[17]  J. García‐Pagán,et al.  Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. , 2001, Gastroenterology.

[18]  C. Klein,et al.  Effect of losartan, an Angiotensin II receptor antagonist, on portal pressure in cirrhosis , 1999, Hepatology.

[19]  D. Harnois.  Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial , 2010 .